- Home
- Equipment
- north america
- renal disease
Show results for
Refine by
Stanford Chemicals Renal Disease Equipment Supplied In North America
1 equipment items found
Manufactured by:Stanford Chemicals Company based inLake Forest, CALIFORNIA (USA)
Losartan competes with the binding of angiotensin II to AT1 receptors. The concentration that inhibits 50% of the binding of angiotensin II (IC50) is 20 nM. Losartan (40 μM) affects ISC but prevents the effect of ANGII on ISC. Losartan significantly reduces Ang II-mediated cell proliferation in endometrial cancer cells. The combination of losartan and anti-miR-155 has a significantly greater ...
